| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Medical Equipment/Supplies/Accessories
|
Compare with Industry peers |
| Website | http://www.polymedicure.com | |
| Market Cap | 15,737.87 Cr. | |
| Enterprise Value(EV) | 15,724.91 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 25.92 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 63.28 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 59.58 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 146.12 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 11.22 | Calculated using Price: 1,639.85 |
| Dividend Yield | 0.18 | Period Ending 2023-03 |
| No. of Shares Subscribed | 9.60 Cr. | 95,971,417 Shares |
| FaceValue | 5 | |
| About Poly Medicure Ltd. | ||
| Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products. | ||
| 1 Day |
|
+0.47% |
| 1 Week |
|
+7.74% |
| 1 Month |
|
+3.76% |
| 3 Month |
|
+18.58% |
| 6 Month |
|
+19.24% |
| 1 Year |
|
+68.19% |
| 2 Year |
|
+88.53% |
| 5 Year |
|
+745.41% |
| 10 Year |
|
+1335.77% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 36.03 | 22.35 | 22.04 | 23.17 | 18.19 | 23.51 | 19.42 | 14.29 | 15.42 | |
| Return on Capital Employed (%) | 38.9 | 25.59 | 24.54 | 25.69 | 22.47 | 24.8 | 21.96 | 17.42 | 19.1 | |
| Return on Assets (%) | 18.97 | 12.64 | 13.06 | 13.82 | 10.49 | 12.95 | 13.15 | 11.08 | 11.9 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 196 | 229 | 272 | 338 | 381 | 435 | 966 | 1,087 | 1,242 | 1,338 | |
| Non Curr. Liab. | 55 | 49 | 72 | 104 | 119 | 139 | 87 | 63 | 42 | 38 | |
| Curr. Liab. | 113 | 109 | 114 | 123 | 181 | 225 | 215 | 227 | 351 | 321 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 364 | 387 | 457 | 565 | 682 | 800 | 1,267 | 1,377 | 1,635 | 1,697 | |
| Non Curr. Assets | 205 | 217 | 252 | 310 | 352 | 450 | 520 | 593 | 770 | 885 | |
| Curr. Assets | 160 | 171 | 205 | 255 | 329 | 350 | 748 | 783 | 865 | 812 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 364 | 387 | 457 | 565 | 682 | 800 | 1,267 | 1,377 | 1,635 | 1,697 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 390 | 412 | 455 | 520 | 611 | 687 | 786 | 923 | 1,115 | 1,305 | |
| Other Income | 8 | 8 | 14 | 14 | 18 | 18 | 18 | 38 | 36 | 52 | |
| Total Income | 398 | 421 | 469 | 535 | 629 | 706 | 805 | 961 | 1,151 | 1,357 | |
| Total Expenditure | -304 | -325 | -362 | -398 | -480 | -521 | -570 | -708 | -848 | -960 | |
| PBIDT | 94 | 96 | 107 | 136 | 150 | 185 | 235 | 253 | 304 | 397 | |
| Interest | -10 | -10 | -9 | -12 | -14 | -20 | -11 | -6 | -11 | -11 | |
| Depreciation | -19 | -21 | -24 | -29 | -37 | -41 | -48 | -54 | -57 | -63 | |
| Taxation | -23 | -18 | -20 | -26 | -35 | -30 | -44 | -49 | -58 | -78 | |
| Exceptional Items | 20 | ||||||||||
| PAT | 62 | 47 | 55 | 71 | 65 | 96 | 136 | 147 | 179 | 246 | |
| Minority Interest | |||||||||||
| Share Associate | 1 | 1 | 3 | ||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 62 | 48 | 55 | 71 | 65 | 96 | 136 | 147 | 179 | 249 | |
| Adjusted EPS | 7 | 5 | 6 | 8 | 7 | 11 | 14 | 15 | 19 | 26 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 66 | 63 | 63 | 56 | 75 | 106 | 128 | 119 | 123 | 191 | |
| Cash Fr. Inv. | -58 | -59 | -31 | -56 | -88 | -101 | -107 | -436 | -85 | -179 | |
| Cash Fr. Finan. | 5 | -6 | -31 | 0 | 16 | -5 | -21 | 317 | -35 | -13 | |
| Net Change | 13 | -2 | 1 | 0 | 3 | 1 | 1 | 0 | 3 | -1 | |
| Cash & Cash Eqvt | 14 | 12 | 13 | 1 | 4 | 4 | 5 | 5 | 8 | 7 |
|
Thu, 02 May 2024
Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 17Th May 2024. POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 inter alia to consider and approve Dear Sir/Madam Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that a meeting of the Board of Director of the Company will be held on Friday the 17th May 2024 inter alia to consider the following:a. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the company for the financial year ended on 31st March 2024.b. To consider recommendation of Final Dividend If any on the Equity Shares for the Financial year ended on 31st March 2024.c. To transact any other matter which the Board may deem fit.In continuation of our intimation regarding closure of trading window vide letter dated 31st March 2024 the Trading Window for dealing in securities of the company shall remain closed till 19th May 2024. |
|
Mon, 22 Apr 2024
Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2024. Pursuant to the Regulation 40(9) of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015 Please find attached the certificate issued by the Practicing Company Secretary for the financial year ended on 31st March 2024. |
|
Thu, 11 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that all activities in relation to share transfer facility are maintained by the Company;s Registrar and Share Transfer Agent viz Mas Services Limited a SEBI approved category-I Registrar & Transfer Agent registered with SEBI (R.NO. INR000000049) during the period from 01st April 2023 to 31st March 2024 (both days inclusive. |
| Thu, 02 May 2024 |
Close Within 52 Week High Zone
|
High Increase in 1 Year
|
High Increase in 2 Years
|
High Increase in 5 Years
|
CCI Overbought Zone
|
